Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Point-Counterpoint: CYP2C19 Genotyping for Clopidogrel.

South Dakota medicine : the journal of the South Dakota State Medical Association - 1 Jan 2017

Larson Eric A, Miller Nathan J

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genotype
Share to Clopidogrel
Share to Cytochrome P-450 CYP2C19
Share to Pharmacogenomic Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Platelet Aggregation Inhibitors

Share to Ticlopidine

Source

Identifiers

PMID: 28810096

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Point-Counterpoint: CYP2C19 Genotyping for Clopidogrel.PMID 28810096Read ↗

Comparative analysis of point-of-care bedside cyp2c19-testing guided anti-platelet therapy versus conventional therapies for cardiovascular diseases: a systematic review and meta-analysis.Semantic proximity Read ↗

Point-Counterpoint: Genotype-Guided Warfarin Therapy.Semantic proximity Read ↗

Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy.Semantic proximity Read ↗

CYP2C19 genotype-guided antiplatelet therapy: promises and pitfalls.Semantic proximity Read ↗

Aiming for precision: CYP2C19 gene polymorphism and clopidogrel resistance in patients with peripheral artery disease.Semantic proximity Read ↗

Clopidogrel and Genotyping.Semantic proximity Read ↗

Genotyping genetic variants of CYP2C19 for precision antiplatelet dosing: state of the art and future perspectives.Semantic proximity Read ↗

Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update.Semantic proximity Read ↗

Clopidogrel and CYP2C19 testing: ready for clinical prime time?Semantic proximity Read ↗

CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx).Semantic proximity Read ↗

Point-Counterpoint: SLCO1B1 Genotyping for Statins.Semantic proximity Read ↗

Clopidogrel PharmacogeneticsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.